Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Taiwan University Hospital

About this trial

To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery. The primary outcomes are psychological distress , and the secondary outcomes are physical symptoms, stress index, and quality of life.

Eligibility criteria

Qualifiers

Aged 18 years or older.

Diagnosed with gynecologic cancer and undergoing surgery.

Willing to receive E-MOTE robot and wear a smart wearable device.

Willing to complete pre-test and post-test questionnaires.

Disqualifiers

Unable to communicate clearly.

Unwilling or unable to participate in the study in its entirety.

Aged 18 years or older.

As a clinical nurse and has cared for patients who received the E-MOTE robot

Trial design

Treatments tested in this trial

  • E-MOTE group

Treatment groups

120 Participants
are divided into 2 treatment groups